CD276 and neoplasm: In the analyses, patients with high tumor B7-H3 expression had a significantly better prognosis than those with low tumor B7-H3 expression (p = 0.0341); however, stromal B7-H3 expression was not statistically associated with 5-year overall survival (Figure 2e–g).